These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31217979)

  • 1. Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.
    Kamal A; Fain C; Park A; Wang P; Gonzalez-Velez E; Leffler DA; Hutfless SM
    Gastroenterol Rep (Oxf); 2019 Jun; 7(3):162-167. PubMed ID: 31217979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Moderate Sprue-Like Enteropathy Associated With Telmisartan.
    Negro A; De Marco L; Cesario V; Santi R; Boni MC; Zanelli M
    J Clin Med Res; 2017 Dec; 9(12):1022-1025. PubMed ID: 29163738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin Receptor Blocker-Related Sprue-like Enteropathy: Review of Food and Drug Administration Adverse Event Reporting System.
    Meader R; Papasotiriou S; Ahdi H; Dang H; Ehrenpreis ED
    Ann Pharmacother; 2024 May; 58(5):494-500. PubMed ID: 37559251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.
    Wenzel RR; Datz C
    Wien Klin Wochenschr; 2019 Oct; 131(19-20):493-501. PubMed ID: 31471672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.
    Mandavdhare HS; Sharma V; Prasad KK; Kumar A; Rathi M; Rana SS
    Intest Res; 2017 Jul; 15(3):419-421. PubMed ID: 28670240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.
    Burbure N; Lebwohl B; Arguelles-Grande C; Green PH; Bhagat G; Lagana S
    Hum Pathol; 2016 Apr; 50():127-34. PubMed ID: 26997446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Olmesartan therapy and enteropathy: About two cases and review of the literature].
    Sadki A; Le Besnerais M; Héron F; Marie I
    Rev Med Interne; 2019 Feb; 40(2):112-116. PubMed ID: 30174111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: Sprue-like enteropathy associated with olmesartan.
    Ianiro G; Bibbò S; Montalto M; Ricci R; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2014 Jul; 40(1):16-23. PubMed ID: 24805127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel enteropathy associated with olmesartan medoxomil treatment.
    Galanopoulos M; Varytimiadis L; Tsigaridas A; Karatzas PS; Archavlis E; Viazis N; Vourlakou C; Mantzaris GJ
    Ann Gastroenterol; 2017; 30(1):131-133. PubMed ID: 28042253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Sprue-Like Enteropathy and Colitis due to Olmesartan: Lessons Learned From a Rare Entity.
    Bashari DR
    Gastroenterology Res; 2020 Aug; 13(4):150-154. PubMed ID: 32864026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea.
    Sotiropoulos C; Sakka E; Diamantopoulou G; Theocharis GJ; Thomopoulos KC
    Cureus; 2021 Aug; 13(8):e17004. PubMed ID: 34540405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.
    You SC; Park H; Yoon D; Park S; Joung B; Park RW
    Korean J Intern Med; 2019 Jan; 34(1):90-98. PubMed ID: 29172402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin Receptor Blockers Associated Enteropathy-Brief Report.
    Gosai N; Gosai F
    J Community Hosp Intern Med Perspect; 2022; 12(3):80-82. PubMed ID: 35711393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study.
    Nishida Y; Takahashi Y; Susa N; Kanou N; Nakayama T; Asai S
    Cardiovasc Diabetol; 2013 Nov; 12():159. PubMed ID: 24180232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of olmesartan and enteropathy outcomes: a multi-database study.
    Dong YH; Jin Y; Tsacogianis TN; He M; Hsieh PH; Gagne JJ
    Aliment Pharmacol Ther; 2018 Mar; 47(6):792-800. PubMed ID: 29359522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five cases of sprue-like enteropathy in patients treated by olmesartan.
    Théophile H; David XR; Miremont-Salamé G; Haramburu F
    Dig Liver Dis; 2014 May; 46(5):465-9. PubMed ID: 24472297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.
    Malfertheiner P; Ripellino C; Cataldo N
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):581-586. PubMed ID: 29457309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper.
    Xue A; Fowler MR; Silverman J; Sturkie E; Raff E
    Cureus; 2023 Jul; 15(7):e41604. PubMed ID: 37559845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprue-like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers.
    Lagana SM; Braunstein ED; Arguelles-Grande C; Bhagat G; Green PH; Lebwohl B
    J Clin Pathol; 2015 Jan; 68(1):29-32. PubMed ID: 25342757
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.